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Pneumomediastinum and subcutaneous emphysema after 
noninvasive ventilation in a COVID-19 patient
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An 80-year-old man was admitted because of persistent fever and dyspnea. Two days before he presented 
at the emergency department with a 5-day history of non-productive cough and fever. Chest X-ray revealed 
bilateral alveolar infiltrates. Blood tests showed mild leukocytosis, increased C-reactive protein and normal 
procalcitonin. Oxygen saturation was 96% at ambient air. High-resolution chest tomography (HRCT) showed 
bilateral ground-glass opacities. SARS-CoV-2 infection was diagnosed via nucleic acid test on nasopharyngeal 
swab. Hydroxychloroquine was started and he was discharged to home isolation. In the following 48 hours his 
symptoms did not improve. At second presentation, oxygen saturation was decreased to 93%, body temperature 
was 39.9°C, and respiratory rate was 30 breaths/min. Physical examination was notable for crackles in both 
lung bases. He was admitted to our COVID-19 ward and supplemented with oxygen through a non-rebreather 
face mask. Antiviral therapy (lopinavir/ritonavir) was added to ongoing hydroxychloroquine for 10 days. 
Intravenous (IV) antibiotics (ceftriaxone plus azithromycin) were also administered from day (D)2 to D7, and 
ceftriaxone alone was extended until D12. He was also receiving thromboprophylaxis (fondaparinux 2.5 mg/day) 
since admission. Although fever decreased within the first 5 days, his respiratory status progressively worsened, 
with a decrease in PaO2/FiO2 to less than 150. Steroid was started at D6 (IV methylpredinisolone 60 mg/die) 
with little improvement. Noninvasive ventilation was then applied (PPEP 6–8 cmH2O), but it was stopped 
after 48 hours because of poor compliance. Repeated HRCT scan showed increased ground-glass opacities and 
parenchymal consolidations (Figure 1). Pneumomediastinum was also observed, together with subcutaneous 
emphysema (Figure 1). Conservative treatment was applied, and antibiotic therapy was resumed because of 
fever relapse. In the following days, he received conventional oxygen supplementation, fever disappeared, but 
no further improvement of respiratory function was observed. He was ultimately transferred to a long-term 
care unit, where he continued receiving supportive and palliative treatment.
Figure 1. A. HRCT scan showing multiple ground-glass opacities with thickening of interlobular and intralobular septa (crazy-paving pattern) 
and a parenchymal consolidation in the left lower lobe. Pneumomediastinum was also observed around the heart, with the presence of connec-
tive tissue septae; B. Pneumomediastinum extended upward between the mediastinal pleura, the aortic arch and the superior mediastinum, 
together with subcutaneous emphysema extending to the soft tissue of the cervico-axillary region, and the lateral thoracic wall
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Pneumomediastinum is an uncommon complication of mechanical ventilation [1]. Spontaneous pneumo-
mediastinum has also been observed in association with several structural lung diseases, including chronic 
obstructive lung disease, asthma, and interstitial lung diseases [1, 2]. More recently it has been reported 
complicating the course of COVID-19 [3]. Both spontaneous and ventilation-associated pneumomediastinum 
has been observed in patients with SARS, with high peak LDH level associated with its development [4]. 
In the presence of diffuse alveolar damage, free air could leak from ruptured alveoli, dissecting along the 
bronchovascular sheaths towards the mediastinum (Macklin effect) [1]. Symptoms and signs include chest 
pain, worsening dyspnea, subcutaneous emphysemas, mediastinal (Hamman’s) crunch on heart auscultation 
[1]. Pneumomediastinum is generally a self-limiting condition [2]. More rarely it could be life-threatening by 
mimicking cardiac tamponade [1]. Here, we reported a case of pneumomediastinum in a patient with severe 
COVID-19-related pneumonia necessitating noninvasive ventilation. Prompt recognition is required during 
ventilatory support as it may promote its progression [5]. In both SARS and COVID-19, pneumomediastinum 
has been associated with a more severe course [3, 4], possibly reflecting massive alveolar and interstitial 
pulmonary injury. The occurrence rate of pneumomediastinum among ventilated COVID-19 patients is still 
unknown. Further data are needed to identify the mechanisms, frequency, risk factors and prognostic role of 
this rare complication of COVID-19.
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